Table 1.
Patient | Age | Sex | Seizure type | Antiepileptic drugs | Symptoms at presentation |
---|---|---|---|---|---|
1 | 60 | F | FC | VPA | Seizure |
2 | 64 | M | GTC | VPA | Seizure |
3 | 63 | F | FC | CBZ | Seizure |
4 | 58 | M | Focal aphasic | OXC | Seizure |
5 | 48 | M | FC | LVT | Seizure |
6 | 66 | M | FS | LVT | Motor aphasia |
7 | 42 | M | FS | OXC | Headache |
8 | 57 | M | Focal inhibitory | LVT | Seizure |
9 | 77 | M | FC | LVT | Seizure |
10 | 64 | M | GTC | LVT | Seizure |
11 | 68 | M | None | None | Headache |
12 | 36 | F | None | None | Headache |
13 | 58 | M | None | None | Motor aphasia |
14 | 71 | M | None | None | Headache |
15 | 37 | F | None | None | Headache |
16 | 65 | M | None | None | Headache |
17 | 61 | M | None | None | Left hemiparesis |
18 | 58 | F | None | None | Headache |
19 | 84 | F | None | None | Headache |
CBZ, carbamazepine; FC, focal clonic; FS, focal sensory with elementary symptoms; GTC, generalized tonic-clonic; LVT, levetiracetam; OXC, oxcarbazepine; VPA, valproic acid.